Target intelligence / Profile preview

Methyltransferase 2B, tRNA N3-cytidine (METTL2B)

Target
METTL2B
Molecular classification
Enzyme, tRNA methyltransferase
01

Overview

Methyltransferase 2B, tRNA N3-cytidine (METTL2B) is a protein-coding gene in humans located on chromosome 7[2][4]. It encodes an S-adenosyl-L-methionine-dependent methyltransferase that catalyzes the N(3)-methylcytidine modification of residue 32 in the anticodon loop of specific tRNA species, including tRNA(Thr)(UGU) and tRNA(Arg)(CCU)[2][3][4]. This modification is implicated in the fine-tuning of translation and maintains the structure and function of certain tRNAs[2][3]. METTL2B is part of a larger family of methyltransferases that primarily act on RNA targets, distinguishing it from DNA or protein methyltransferases[1]. METTL2B is expressed in the cytoplasm, functions alongside highly similar paralogs (notably METTL2A), and exhibits lower tRNA methylation activity compared to METTL2A due to specific amino acid differences influencing its enzymatic activity[3]. Although METTL2B has no well-established direct disease associations or targeted therapeutics, it represents an important component of the cellular RNA modification machinery, contributing to epitranscriptomic regulation[1][3][4].

Other names
METLFLJ11350METTL2METTL2APSENIP1methyltransferase-like protein 2BtRNA N(3)-cytidine methyltransferase METTL2Bmethylcytidinemethyltransferase like 2BtRNA N(3)-methylcytidine methyltransferase METTL2B
02

Biological functions

tRNA modificationEpitranscriptomic regulationRNA methylation
03

Disease associations

Other (no strong, direct link to major diseases; one reported association with cystinuria[4])

Beyond the preview

Go deeper on Methyltransferase 2B, tRNA N3-cytidine (METTL2B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Methyltransferase 2B, tRNA N3-cytidine (METTL2B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call